HQL ETF

HQL ETF
See how much of HQL you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials

Net Assets
-
Expense Ratio
-
Dividend Yield (Current)
-
Holdings
0
Inception Date
-
Fund Family
abrdn Life Sciences Investors
Asset Class
PRO
Legal Structure
PRO

Performance

See how much of HQL you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
REGNRegeneron Pharmaceuticals Inc7.35%
AMGNAmgen Inc7.28%
GILDGilead Sciences Inc6.61%
VRTXVertex Pharmaceuticals Inc4.53%
ALNYAlnylam Pharmaceuticals Inc3.45%
Top 10 Concentration: 43.43%
Download all 131 holdings for HQL
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO

HQL ETF Overview

HQL ETF (abrdn Life Sciences Investors) is managed by abrdn Life Sciences Investors. various sectors.

HQL performance shows data across multiple time periods..

HQL top holdings include Regeneron Pharmaceuticals Inc (7.4%), Amgen Inc (7.3%), Gilead Sciences Inc (6.6%), Vertex Pharmaceuticals Inc (4.5%), Alnylam Pharmaceuticals Inc (3.5%). Go to all HQL holdings, HQL sectors, or HQL dividends.

HQL can be compared against other funds. Use HQL overlap to find shared positions, or HQL vs another fund for a side-by-side view. HQL alternatives are available via the screener, along with tax-loss harvesting opportunities.

Top 10 Holdings (43.4% of portfolio)

#TickerNameSectorWeight
1REGNRegeneron Pharmaceuticals IncUnknown7.35%
2AMGNAmgen IncUnknown7.28%
3GILDGilead Sciences IncUnknown6.61%
4VRTXVertex Pharmaceuticals IncUnknown4.53%
5ALNYAlnylam Pharmaceuticals IncUnknown3.45%
6BMRNBioMarin Pharmaceutical IncUnknown3.44%
7-NEUROVANCE MILESTONE INTERESTUnknown3.02%
8GVMXXState Street Global AdvisorsUnknown2.92%
9IM8NInsmed IncUnknown2.42%
10ARGXArgenx SEUnknown2.41%